Hudson Valley Hematology Oncology Associates

Poughkeepsie, New York 12601

0 studies enrolling now · 6 studies all time

What they study most

Breast Adenocarcinoma, Breast Cancer, Hormone Receptor Positive, Multiple Myeloma, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7

Studies at this site

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Multiple Myeloma Patient Registry — Stopped early
• A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma — Completed
• Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer — Completed